(Bloomberg) — US scientists haven’t gotten a handle on how to effectively track bird flu, three months after a Texas dairy worker was diagnosed with the virus. That’s impeding the ability to create a vaccine to protect against the spread among people. Bird flu’s health risk to the general public remains low, according to US officials. But if the virus becomes more dangerous, it’s unclear we’ll have a shot that works, according to Kate Broderick, a vaccine developer at Maravai LifeSciences Holdings, who’s helped develop shots against Ebola and Zika. Broderick said that scientists don’t have a clear picture of the viral strain that’s currently circulating and whether the virus is more widesp
Hence then, the article about bird flu vaccine faces hurdles without better data critics say bnn bloomberg was published today ( ) and is available oncanadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Bird Flu Vaccine Faces Hurdles Without Better Data, Critics Say – BNN Bloomberg )